Ascendis Pharma A/S Statistics
NASDAQ: ASNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
228.41+2.36 (+1.04%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Ascendis Pharma A/S by the numbers
Ascendis Pharma A/S has a market capitalization of $15.03 billion based on 65.80M shares outstanding. Its trailing P/E ratio is 17.3, below the 3-company peer median of 149.2, and its forward P/E is 21.1. The stock trades 7.8% below its 50-day average and 3.1% below its 200-day average.
Average daily trading volume is 656.21K shares, or about $149.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ASND valuation vs. peer median
| Metric | ASND | Peer median | Difference |
|---|---|---|---|
| Market cap | $15.03B | $12.10B | +24% |
| P/E (TTM) | 17.3 | 149.2 | -88% |
| Forward P/E | 21.1 | 18.2 | +16% |
| Avg. volume | 656.21K | 2.83M | -77% |
Peer median across 8 companies: SMMT, BBIO, CORT, MDGL, ELAN, BMRN, RDY, VTRS.
Valuation
- Market cap
- $15.03B
- P/E (TTM)
- 17.32
- Forward P/E
- 21.11
- EPS (TTM)
- $13.19
- Shares outstanding
- 65.80M
Price and trading
- Previous close
- 226.05
- Open
- 224.36
- Day range
- 223.05 – 229.00
- 52-week range
- 186.05 – 282.15
- 52-week change
- +8.84%
- 50-day moving average
- 247.63
- 200-day moving average
- 235.76
- Beta
- —
- Volume
- 820.54K
- Average volume
- 656.21K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 30, 2026
Additional statistics
- Market Cap
- 15.03B
- Pe
- 17.32
- Forward Pe
- 21.11
- Eps
- 13.19
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 282.15
- Week52 Low
- 186.05
- Avg Volume
- 656.21K
- Shares Outstanding
- 65.80M
- Ma50
- 247.63
- Ma200
- 235.76
- Earnings Date
- Apr 30, 2026
- Pct From52w High
- -19.05%
- Pct From52w Low
- 22.77%